PNP

Evidence review: Maternal mental conditions drive climbing death rate in U.S.

Retrieved on: 
Wednesday, February 21, 2024
Mental health, Woman, PNP, Suicide, Infection, Prenatal development, Hospital, Public health, Bleeding, MPA, Fatality, Maternal death, Mental, DSM-IV codes, Pregnancy, Communication, Death, Internal bleeding, Risk, Health, JAMA Psychiatry, FACOG, University, Infant, Disease, Mother, White, Health policy, Maternal health, Child, Mortality, Drug overdose, George Washington University, Research, Medicine, Depression

“The contribution of mental health conditions to the maternal morbidity and mortality crisis that we have in America is not widely recognized,” said Katherine L. Wisner, M.D.

Key Points: 
  • “The contribution of mental health conditions to the maternal morbidity and mortality crisis that we have in America is not widely recognized,” said Katherine L. Wisner, M.D.
  • , associate chief of Perinatal Mental Health and member of the Center for Prenatal, Neonatal & Maternal Health Research at Children’s National.
  • Overdose and other maternal mental health conditions are taking the lives of more than twice as many women as postpartum hemorrhage, the second leading cause of maternal death.
  • Mental health conditions such as suicide or opioid overdose are to blame for nearly 23% of maternal deaths in America, according to reports from three dozen Maternal Morbidity and Mortality Review Committees, which are state-based organizations that review each maternal death within a year of pregnancy.

Balluff Offers Simplified I/O Hubs with Lightweight, Sustainable Housings

Retrieved on: 
Tuesday, February 6, 2024
IO-Link, Multimedia, Robotics, Vibration, NPN, Shock, Housing, Temperature, Documentation, PNP, IP67, Video game

FLORENCE, Ky., Feb. 6, 2024 /PRNewswire-PRWeb/ -- Companies wanting to add IO-Link to their production have a new option – Balluff's simplified I/O hubs.

Key Points: 
  • FLORENCE, Ky., Feb. 6, 2024 /PRNewswire-PRWeb/ -- Companies wanting to add IO-Link to their production have a new option – Balluff's simplified I/O hubs.
  • Balluff's simplified I/O hubs provide fast, effective signal transmission and reduced signal runtimes.
  • An extension of Balluff's broad IO-Link portfolio, these new networking blocks offer simple handling and basic I/O functions in compact, lightweight, and sustainable housing.
  • Designed with deliberate simplicity, these new hubs deliver I/O functions without complex add-ons that aren't needed for some applications.

NuMLM: Hologram Sciences' New AI-Powered Solution Targeting Clinical Malnutrition

Retrieved on: 
Tuesday, February 6, 2024
Health, Technology, Hospitals, Health Technology, Fitness & Nutrition, Managed Care, Artificial Intelligence, Multimedia, Mayo Clinic, Science, Malnutrition, Patient, PNP, Food, Database, Risk, Nursing

NuMLM addresses the large-scale challenge of correctly assessing individual patient nutrition, a widely documented and operationally intensive obstacle to optimizing patient outcomes.

Key Points: 
  • NuMLM addresses the large-scale challenge of correctly assessing individual patient nutrition, a widely documented and operationally intensive obstacle to optimizing patient outcomes.
  • NuMLM's precise and timely tracking of patients' nutritional intake is essential for the PNP to suggest appropriate interventions and alert clinical staff.
  • Ian Brady, CEO of Hologram Sciences, stated, 'We're addressing a critical gap in patient care and applying AI to a clinical need that will dramatically benefit from personalization at scale.
  • Brady added, “Our aim is to apply advanced technology to widespread clinical needs, serving people's wellbeing first and foremost.

Sirnaomics to Present Latest Developments of STP705 for Focal Fat Reduction at IMCAS World Congress 2024

Retrieved on: 
Monday, February 5, 2024
Poster, FFR, Plastic surgery, Division, Clinical trial, Therapy, Safety, PNP, RNA interference, University of Miami, Phase, University, Conference

and SUZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, presented the latest developments on Polypeptide Nanoparticle (PNP) platform, and its pipeline program STP705 for Focal Fat Reduction's positive clinical data, at IMCAS World Congress 2024, which is taking place in Paris from February 1st - 3rd, 2024.

Key Points: 
  • and SUZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, presented the latest developments on Polypeptide Nanoparticle (PNP) platform, and its pipeline program STP705 for Focal Fat Reduction's positive clinical data, at IMCAS World Congress 2024, which is taking place in Paris from February 1st - 3rd, 2024.
  • Previously, Sirnaomics had reported that a poster with positive clinical data of STP705 for focal fat reduction (FFR) was presented at the 2023 Fall Clinical Dermatology Conference.
  • The safety and efficacy results of this Phase I study support further investigation of STP705 as a potential alternative to other injectables for FFR.
  • The positive data from the Phase I clinical study has led to the Group advancing the program to the Phase II clinical study stage.

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Retrieved on: 
Sunday, January 7, 2024
Biotechnology, Health, Genetics, Pharmaceutical, Clinical Trials, SCD, Kingdom, Blue Shield, Conference, T1D, Sickle cell disease, Gene editing, Blue Cross, Pain, Messenger, EMA, FDA, PDUFA, Cystic fibrosis, Insulin, Vertex Pharmaceuticals, Abdominoplasty, European Medicines Agency, Sciatica, SAD, PNP, Glycated hemoglobin, Patient, TDT, Safety, Diabetes, Acceleration, Hypoglycemia, CFTR, VRTX, CHMP, Pharmaceutical industry

Epidemiology update: Vertex revised its estimates for the number of patients living with cystic fibrosis from ~88,000 to ~92,000 in the U.S., Europe, Australia, and Canada.

Key Points: 
  • Epidemiology update: Vertex revised its estimates for the number of patients living with cystic fibrosis from ~88,000 to ~92,000 in the U.S., Europe, Australia, and Canada.
  • The FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of March 30, 2024, for CASGEVY in TDT.
  • VX-993: Vertex also anticipates initiating a Phase 2 study with an oral formulation of VX-993 for the treatment of PNP in 2024.
  • A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com , in the "Investors" section under the "News and Events" page.

20Med Therapeutics Appoints Industry Veteran Hugo Fry as Chief Business Officer to Expedite mRNA Vaccine Delivery Platform Program

Retrieved on: 
Wednesday, November 29, 2023
Commercialization, LNP, Sanofi, London Business School, Drug discovery, Messenger, Nuclear power plant, CEPI, JPMorgan Chase, Therapy, Duke University, University, Market access, TouchLight, Regulatory affairs, PNP, Publication, Infection, Vaccine

Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the appointment of Hugo Fry as Chief Business Officer.

Key Points: 
  • Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the appointment of Hugo Fry as Chief Business Officer.
  • Hugo Fry has 29 years of leadership experience in the pharmaceutical and biotechnology industry across multiple business models, therapeutic areas, and companies, including Sanofi.
  • Hugo has a strong and recent track record of business development and licensing deals in the pharma and biotech sectors.
  • +++ Meet the 20Med Therapeutics team in San Francisco during the JPMorgan week, January 8-12, 2024 to discuss partnering opportunities around our PNP mRNA vaccine delivery platform +++

VOOPOO DRAG X2 and DRAG S2 with PnP X Platform have Arrived in the MENA

Retrieved on: 
Friday, December 22, 2023
Tobacco, Retail, MOD, Multimedia, PNP, Nicotine, MTL, Static pressure, DTL, POD, Transformer

VOOPOO is excited to announce the arrival of the VOOPOO DRAG X2 , DRAG S2 with PnP X platform in the Middle East and North Africa market.

Key Points: 
  • VOOPOO is excited to announce the arrival of the VOOPOO DRAG X2 , DRAG S2 with PnP X platform in the Middle East and North Africa market.
  • View the full release here: https://www.businesswire.com/news/home/20231222903013/en/
    Based on the PnP platform, VOOPOO PnP X platform brings a long-lasting coil lifespan without flavor fading and coil burning.
  • DRAG X2 comes with PnP X Cartridge DTL (with PnP X 0.15 Ω/0.3 Ω).
  • It’s worth mentioning that the cartridges and coils of VOOPOO PnP X coils are only compatible with DRAG X2 and DRAG S2.

CIP Safety Block Offers IP67 Protection to Connect Safety PLC and Safety Nodes

Retrieved on: 
Monday, November 27, 2023
Acquisition, CAT4, IEC, ISO, DeviceNet, PNP, Ethernet, IEC 61508, CIP, Communication, Control, Common Management Information Protocol, IP67, Integration, Risk management, Safety

FLORENCE, Ky., Nov. 27, 2023 /PRNewswire-PRWeb/ -- Balluff's new CIP Safety I/O module safely connects sensors and actuators to industrial controllers, even in harsh environments. Its IP67 protection rating means it can be mounted directly on the machine, like Balluff's IO-Link and standard I/O modules, to easily connect safety devices without spending time and effort on traditional wiring terminations.

Key Points: 
  • "Like Balluff's expansive IO-Link portfolio, the CIP safety block is easy to connect, easy to troubleshoot, and easy to maintain for machine builders and end customers alike."
  • It seamlessly integrates with Rockwell safety PLCs, and it also comes with Balluff's Safety Networking Configuration tool to easily configure its use with other safety PLCs.
  • CIP uses the EtherNet/IP protocol to provide fail-safe communication between Safety PLC and Safety nodes over the same Ethernet/IP network as other devices such as Balluff IO-Link masters and devices.
  • Like Balluff's expansive IO-Link portfolio, the CIP safety block is easy to connect, easy to troubleshoot, and easy to maintain for machine builders and end customers alike.

Virtek Vision Unveils Game-Changing Iris 3D Software Update for Enhanced Productivity and Controlled Workflow

Retrieved on: 
Tuesday, October 31, 2023
3D, United Kingdom, CAD, Product management, AF Corse, Android, Gerber Scientific, PNP, IOS, CAMX, Education minister, 3D printing, Engineering, Booth, Iris

WATERLOO, ON, Oct. 31, 2023 /PRNewswire/ -- Virtek Vision announces the latest release of its Iris™ 3D software with advanced features that deliver more information and control to the operator during the manufacturing process, helping to increase productivity.

Key Points: 
  • WATERLOO, ON, Oct. 31, 2023 /PRNewswire/ -- Virtek Vision announces the latest release of its Iris™ 3D software with advanced features that deliver more information and control to the operator during the manufacturing process, helping to increase productivity.
  • Virtek's Iris 3D combines laser projection with 3D vision technology to locate an object in 3D space instantaneously.
  • Also compatible with the latest software release is the new Iris mobile app that enables operators to control Iris software directly at the tool or work surface using an Android or iOS mobile device.
  • For more than a decade, leading manufacturers in aerospace, composites and industrial fabrication have harnessed the power of Iris 3D software to streamline day-to-day operations and improve business profitability.

OrthoPediatrics Corp. Launches Pediatric Nailing Platform | Tibia

Retrieved on: 
Thursday, October 19, 2023
Nail, Anatomy, FDA, Deformity, Food, Elective surgery, Tibia, Orthopediatrics, Regulation of tobacco by the U.S. Food and Drug Administration, Trauma, OP, Extremities, Surgeon, PNP, Fracture, Patient, Dentistry

WARSAW, Ind., Oct. 19, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it has released the new Pediatric Nailing Platform TIBIA system and successfully completed the first cases in its limited launch.

Key Points: 
  • WARSAW, Ind., Oct. 19, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it has released the new Pediatric Nailing Platform TIBIA system and successfully completed the first cases in its limited launch.
  • Part of the Trauma & Deformity Correction suite of products, PNP Tibia represents another pediatric-focused solution for treating patients with fractures and deformities in the lower extremities.
  • It expands the Company’s offering to 52 unique systems designed specifically to help treat the needs of pediatric patients.
  • The PNP Tibia System features rigid cannulated nails, ranging in diameters from 7mm-12mm, and includes specialized instrumentation to facilitate multiple surgical techniques.